Arzneiwerk AG VIDA (XTER:TLIK) Change In Receivables : €0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Arzneiwerk AG VIDA Change In Receivables?

Arzneiwerk AG VIDA's change in receivables for the quarter that ended in Sep. 2024 was €0.00 Mil. It means Arzneiwerk AG VIDA's Accounts Receivable stayed the same from Jun. 2024 to Sep. 2024 .

Arzneiwerk AG VIDA's change in receivables for the fiscal year that ended in Dec. 2023 was €0.00 Mil. It means Arzneiwerk AG VIDA's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

Arzneiwerk AG VIDA's Accounts Receivable for the quarter that ended in Sep. 2024 was €0.98 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Arzneiwerk AG VIDA's Days Sales Outstanding for the three months ended in Sep. 2024 was 6.03.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Arzneiwerk AG VIDA's liquidation value for the three months ended in Sep. 2024 was €-12.63 Mil.

Arzneiwerk AG VIDA Change In Receivables Historical Data

The historical data trend for Arzneiwerk AG VIDA's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arzneiwerk AG VIDA Change In Receivables Chart

Arzneiwerk AG VIDA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

Arzneiwerk AG VIDA Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Arzneiwerk AG VIDA Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Arzneiwerk AG VIDA (XTER:TLIK) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Arzneiwerk AG VIDA's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.978	/	14.796	*	91
=	6.03

2. In Ben Graham's calculation of liquidation value, Arzneiwerk AG VIDA's accounts receivable are only considered to be worth 75% of book value:

Arzneiwerk AG VIDA's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1.082	-	17.114	+	0.75 * 0.978	+	0.5 * 5.346
=	-12.63

Arzneiwerk AG VIDA Change In Receivables Related Terms

Thank you for viewing the detailed overview of Arzneiwerk AG VIDA's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Arzneiwerk AG VIDA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Arzneiwerk AG VIDA (XTER:TLIK) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

TLIK:Germany TLIK:Germany

Address

Ordensmeisterstrasse 15-16, Berlin, DEU, 12099

Website

https://www.arzneiwerk.ag

Arzneiwerk AG VIDA is active in the pharmaceutical industry. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry. The company focuses on the growth area of specialty pharma in Germany and Europe which usually includes high-priced drugs for chronic, complex, or rare diseases such as oncology, neurology, autoimmune diseases, ophthalmology, hemophilia, and infectious diseases.

Arzneiwerk AG VIDA Headlines

No Headlines